Management of Peyronie's Disease With Adipose Tissue Stem Cell

NCT ID: NCT02414308

Last Updated: 2015-04-10

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

20 participants

Study Classification

INTERVENTIONAL

Study Start Date

2013-06-30

Study Completion Date

2016-07-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Erectile dysfunction is growing in prevalence all over the world and one of the most existing disease in old age patients There is many lines of treatment concerning the status of patient like psychosexual, medical, and surgical treatment But Pyronie's disease is common now among people especially diabetics, and the role of treatment still controversial in results We can start conservative treatment and then surgical treatment if fail but the outcome still not convinced Many patients refuse to fix penile prosthesis and to make operation like nesbite for probability of shortening of penis We start to use stem cell in patients have erectile dysfunction and Peyronie's disease The injection of stem cell will be at corpora cavernosa and intra dorsal penile artery under Doppler device guidance

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Peyronie's disease associated with erectile dysfunction nan be treated by different methods We start to treat such patients with adipose tissue stem cell Harvesting stem cell from adipose tissue and injected into corpora cavernosa and penile artery and we assess quality of erection through patient history and penile duplex and also assess plaque size and other symptoms related to Peyronie's disease

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Erectile Dysfunction Peyronie' Disease

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Adipose tissue stem cell injection

The stem cell will be harvested by liposuction and injection will be at corpora cavernosa and dorsal penile artery

Group Type EXPERIMENTAL

Adipose tissue stem cell injection

Intervention Type DRUG

Stem cell will be harvested through adipose tissue by liposuction and isolation occurred Injection will distribute through corpora cavernosa and dorsal penile artery

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Adipose tissue stem cell injection

Stem cell will be harvested through adipose tissue by liposuction and isolation occurred Injection will distribute through corpora cavernosa and dorsal penile artery

Intervention Type DRUG

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* erectile dysfunction associated with Peyroni's diseas

Exclusion Criteria

* nil
Eligible Sex

MALE

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Man Clinic for Andrology, Male Infertility and Sexual Dysfunction

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Khaled Abdulmoneim Gadalla

Dr

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Khaled A Gadalla, MD, ABS

Role: PRINCIPAL_INVESTIGATOR

Man clinic

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Man clinic for andrology and male infertility

Cairo, Cairo Governorate, Egypt

Site Status RECRUITING

Man clinic

Cairo, , Egypt

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Egypt

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Khaled A Gadalla, MD, ABS

Role: CONTACT

20222725025

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Khaled A Gadalla, MD, ABS

Role: primary

20222725025

Khaled A Gadalla, MD, ABS

Role: primary

20222725025

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

003

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Efficacy of Wharton Jelly in Erectile Dysfunction
NCT03751735 COMPLETED PHASE1/PHASE2
Erectile Dysfunction Treatment Using Stem Cells
NCT06550752 NOT_YET_RECRUITING PHASE1/PHASE2